ArticleCurrent protocols2026
A Facile Strategy for 3'-Terminal Functionalization of DNA and RNA via On-Column Conjugation with Integration into Tandem Oligonucleotide Synthesis.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Amino-functionalized oligonucleotides are valuable tools in therapeutics, biosensing, and nanotechnology. Although 5'-terminal modifications are readily accessible, incorporation at the 3'-terminus remains more challenging and often requires pre-functionalized solid supports or specialized reagents. To address these limitations, we developed a bis(hydroxymethyl)malonyl CPG (CPR II CPG) solid support that can be activated with N,N'-disuccinimidyl carbonate (DSC) to generate a carbamate-forming platform. Using this support, we established an on-support bis-carbamate construction strategy that enables efficient incorporation of amino modifiers in high yields and crude purities. Furthermore, by leveraging a trifunctional linker (1-amino-3-(((4-methoxyphenyl)diphenylmethyl)amino)propan-2-ol), we developed a modular approach in which one amine is tethered to the solid support while the second amine can be selectively detritylated and conjugated to diverse ligands. The free hydroxyl group can then be used to extend an oligonucleotide through automated solid-phase synthesis. This strategy accommodates a broad range of ligands through multiple conjugation chemistries, including NHS esters/carbonates and EDC-mediated amide bond formation, with good conversions. Finally, we describe a tandem oligonucleotide synthesis (TOS) protocol for generating strands of DNA bearing ligands at defined terminal positions, enabling rapid access to highly modified oligonucleotides. All oligonucleotide conjugates were purified using standard workflows, including strong anion exchange high-performance liquid chromatography (SAX-HPLC), and characterized by mass spectrometry (MS). © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Synthesis of R-CPG and incorporation of bis-amino modifiers such as putrescine Basic Protocol 2: Synthesis of MMTr-1,3-diamino-2-propanol (compound 2) and R-CPG functionalization Alternate Protocol 1: EDC-mediated ligand-amine coupling (4-bromobenzoic acid) and DNA synthesis Alternate Protocol 2: NHS-carbonate-mediated ligand coupling (Boc-OSu) and RNA synthesis Basic Protocol 3: Conjugational tandem oligonucleotide synthesis (cTOS) of highly modified DNA duplexes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.